Intensive care management of the patient with cystic fibrosis
Ted M Kremer1, Robert G Zwerdling, Peter H Michelson
1Department of Pediatrics, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA. kremert@ummhc.org
Insights
Cystic fibrosis (CF) patients now live into adulthood due to improved therapies. This article guides intensive care physicians on managing CF complications and end-of-life care for adult CF patients.
Area of Science:
- Pulmonology
- Critical Care Medicine
- Genetics
Background:
- Cystic fibrosis (CF) was historically a pediatric disease.
- Therapeutic advancements have significantly increased patient lifespan into adulthood.
- Adult CF patients present unique challenges in intensive care settings.
Purpose of the Study:
- To educate intensive care unit (ICU) physicians on adult cystic fibrosis care.
- To outline ICU-specific complications in cystic fibrosis patients.
- To provide current clinical management recommendations for adult CF patients.
Main Methods:
- Review of current literature on cystic fibrosis management.
- Analysis of common ICU complications in cystic fibrosis.
- Synthesis of evidence-based recommendations for intensivist care.
Main Results:
- Pulmonary decline due to obstruction, infection, and inflammation is a primary concern.
- Non-pulmonary organ involvement (liver, pancreas, intestines, kidneys) requires careful consideration.
- Lung transplantation is an option, but post-transplant survival varies.
Conclusions:
- Adult cystic fibrosis patients require specialized ICU management.
- Multisystem complications necessitate a comprehensive approach.
- Palliative and end-of-life care planning is crucial for patient and family support.
Abstract:
Cystic fibrosis was previously thought to be a disease of childhood. With a better understanding of this condition along with improvements in therapy, patients with cystic fibrosis are now living well into adulthood. The aim of this article is to familiarize the intensive care unit physician with cystic fibrosis care, to discuss complications associated with cystic fibrosis specifically related to the intensive care unit, and to detail the current recommendations for the clinical management of the patient with cystic fibrosis. With advancing disease, the most severely affected organs are the lungs. Obstruction, infection, and inflammation contribute to the decline of pulmonary function, ultimately leading to death. Some patients may be eligible for lung transplantation, but choosing wisely will affect posttransplant survival. Because other organs are affected by the genetic defect and associated treatments, serious complications related to the liver, pancreas, intestines, and kidneys must be considered by the intensivist faced with a patient with cystic fibrosis. As practitioners, the fact that not all patients will survive and help our patients and families gracefully through the end-of-life process should be accepted.
More Related Videos
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Acute Respiratory Failure-III
